Electromed, Inc. R&D Expense

Quick Answer

Electromed, Inc. reported R&D Expense of $996.0 thousand for fiscal year 2025.

Electromed, Inc. R&D Expense — Annual History

Fiscal Year R&D Expense YoY Change
2025 $996.0K +51.8%
2024 $656.0K -28.4%
2023 $916.0K -32.4%
2022 $1.36M -21.3%
2021 $1.72M +64.0%
2020 $1.05M +80.0%
2019 $583.3K +132.0%
2018 $251.4K -57.9%
2017 $596.9K +56.9%
2016 $380.4K +20.5%
2015 $315.6K -32.3%
2014 $466.1K -22.8%
2013 $603.4K -34.5%
2012 $920.8K -10.9%
2011 $1.03M

Quarterly R&D Expense

Quarter Ending R&D Expense YoY QoQ
December 31, 2025 $384.0K +53.0% +59.3%
September 30, 2025 $241.0K +45.2% -13.0%
March 31, 2025 $277.0K +65.9% +10.4%
December 31, 2024 $251.0K +134.6% +51.2%
September 30, 2024 $166.0K -19.4% -0.6%
March 31, 2024 $167.0K +0.6% +56.1%
December 31, 2023 $107.0K -30.5% -48.1%
September 30, 2023 $206.0K -30.9% +24.1%
  • Electromed, Inc. showed an increase of +51.8% in R&D Expense compared to the prior fiscal year.
  • Over the 2011–2025 period, Electromed, Inc.’s r&d expense has declined by 3.6% (from $1.03 million to $996.0 thousand).
  • The most recent figure is from Electromed, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 26, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment